IBDEI0CK ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5616,1,3,0)
 ;;=3^285.21
 ;;^UTILITY(U,$J,358.3,5616,1,4,0)
 ;;=4^AMEMIA,ESRD
 ;;^UTILITY(U,$J,358.3,5616,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,5617,0)
 ;;=285.9^^28^371^2
 ;;^UTILITY(U,$J,358.3,5617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5617,1,3,0)
 ;;=3^285.9
 ;;^UTILITY(U,$J,358.3,5617,1,4,0)
 ;;=4^ANEMIA NOS
 ;;^UTILITY(U,$J,358.3,5617,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,5618,0)
 ;;=413.9^^28^371^4
 ;;^UTILITY(U,$J,358.3,5618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5618,1,3,0)
 ;;=3^413.9
 ;;^UTILITY(U,$J,358.3,5618,1,4,0)
 ;;=4^ANGINA PECTORIS NEC/NOS
 ;;^UTILITY(U,$J,358.3,5618,2)
 ;;=^87258
 ;;^UTILITY(U,$J,358.3,5619,0)
 ;;=427.9^^28^371^5
 ;;^UTILITY(U,$J,358.3,5619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5619,1,3,0)
 ;;=3^427.9
 ;;^UTILITY(U,$J,358.3,5619,1,4,0)
 ;;=4^CARDIAC DYSRHYTHMIA NOS
 ;;^UTILITY(U,$J,358.3,5619,2)
 ;;=^10166
 ;;^UTILITY(U,$J,358.3,5620,0)
 ;;=496.^^28^371^6
 ;;^UTILITY(U,$J,358.3,5620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5620,1,3,0)
 ;;=3^496.
 ;;^UTILITY(U,$J,358.3,5620,1,4,0)
 ;;=4^CHR AIRWAY OBSTRUCT NEC
 ;;^UTILITY(U,$J,358.3,5620,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,5621,0)
 ;;=428.0^^28^371^7
 ;;^UTILITY(U,$J,358.3,5621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5621,1,3,0)
 ;;=3^428.0
 ;;^UTILITY(U,$J,358.3,5621,1,4,0)
 ;;=4^CONGESTIVE HEART FAILURE
 ;;^UTILITY(U,$J,358.3,5621,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,5622,0)
 ;;=274.9^^28^371^8
 ;;^UTILITY(U,$J,358.3,5622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5622,1,3,0)
 ;;=3^274.9
 ;;^UTILITY(U,$J,358.3,5622,1,4,0)
 ;;=4^GOUT NOS
 ;;^UTILITY(U,$J,358.3,5622,2)
 ;;=^52625
 ;;^UTILITY(U,$J,358.3,5623,0)
 ;;=274.10^^28^371^9
 ;;^UTILITY(U,$J,358.3,5623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5623,1,3,0)
 ;;=3^274.10
 ;;^UTILITY(U,$J,358.3,5623,1,4,0)
 ;;=4^GOUTY NEPHROPATHY NOS
 ;;^UTILITY(U,$J,358.3,5623,2)
 ;;=^265113
 ;;^UTILITY(U,$J,358.3,5624,0)
 ;;=272.4^^28^371^10
 ;;^UTILITY(U,$J,358.3,5624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5624,1,3,0)
 ;;=3^272.4
 ;;^UTILITY(U,$J,358.3,5624,1,4,0)
 ;;=4^HYPERLIPIDEMIA NEC/NOS
 ;;^UTILITY(U,$J,358.3,5624,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,5625,0)
 ;;=252.00^^28^371^12
 ;;^UTILITY(U,$J,358.3,5625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5625,1,3,0)
 ;;=3^252.00
 ;;^UTILITY(U,$J,358.3,5625,1,4,0)
 ;;=4^HYPERPARATHYROIDISM NOS
 ;;^UTILITY(U,$J,358.3,5625,2)
 ;;=^331438
 ;;^UTILITY(U,$J,358.3,5626,0)
 ;;=588.89^^28^371^11
 ;;^UTILITY(U,$J,358.3,5626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5626,1,3,0)
 ;;=3^588.89
 ;;^UTILITY(U,$J,358.3,5626,1,4,0)
 ;;=4^HYPERPARATHYROID w/ IMPAIR REN FNC
 ;;^UTILITY(U,$J,358.3,5626,2)
 ;;=^88036
 ;;^UTILITY(U,$J,358.3,5627,0)
 ;;=356.9^^28^371^13
 ;;^UTILITY(U,$J,358.3,5627,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5627,1,3,0)
 ;;=3^356.9
 ;;^UTILITY(U,$J,358.3,5627,1,4,0)
 ;;=4^IDIO PERIPH NEURPTHY NOS
 ;;^UTILITY(U,$J,358.3,5627,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,5628,0)
 ;;=588.89^^28^371^14
 ;;^UTILITY(U,$J,358.3,5628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5628,1,3,0)
 ;;=3^588.89
 ;;^UTILITY(U,$J,358.3,5628,1,4,0)
 ;;=4^IMPAIR REN FUNCT DIS NEC
 ;;^UTILITY(U,$J,358.3,5628,2)
 ;;=^88036
 ;;^UTILITY(U,$J,358.3,5629,0)
 ;;=411.1^^28^371^15
 ;;^UTILITY(U,$J,358.3,5629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5629,1,3,0)
 ;;=3^411.1
 ;;^UTILITY(U,$J,358.3,5629,1,4,0)
 ;;=4^INTERMED CORONARY SYND
 ;;^UTILITY(U,$J,358.3,5629,2)
 ;;=^7455
 ;;^UTILITY(U,$J,358.3,5630,0)
 ;;=428.1^^28^371^16
 ;;^UTILITY(U,$J,358.3,5630,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI0CK
